• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER MUSCULAR VSD OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER MUSCULAR VSD OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-VSD-MUSC-012
Device Problem Human-Device Interface Problem (2949)
Patient Problem High Blood Pressure/ Hypertension (1908)
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in a subsequent submission.
 
Event Description
It was reported through a research article titled, "periventricular closure of muscular ventricular septal defects in infants with echocardiographic guidance only" that between january 2006 and may 2010, eight infants with nine large muscular (apical) vsds underwent periventricular device closure in a nonhybrid operating room, with transesophageal and epicardial echocardiography guidance.Nine amplatzer muscular vsd devices with a mean size of 10 (4-14) mm were deployed.One patient with holt-oram syndrome was reported to have a significant residual shunt post procedure.The patient remained with residual shunt and pulmonary hypertension and could not be weaned from mechanical ventilatory support and was finally re-operated eight days later.The device was removed and a large, single vsd was successfully implanted.The post-operative course was reported to be uneventful.
 
Manufacturer Narrative
An event of residual shunt was reported.A more comprehensive assessment could not be performed since the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications at the time of commercialization.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER MUSCULAR VSD OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key10049708
MDR Text Key190908264
Report Number2135147-2020-00194
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
PMA/PMN Number
P040040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial,Followup
Report Date 05/27/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9-VSD-MUSC-012
Device Catalogue Number9-VSD-MUSC-012
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 04/29/2020
Initial Date FDA Received05/12/2020
Supplement Dates Manufacturer Received05/23/2020
Supplement Dates FDA Received05/27/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Other; Required Intervention;
Patient Age7 YR
Patient Weight6
-
-